Niraparib

4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Niraparib
Treatment and conditionWhere it standsTrials
Niraparib for cholangiocarcinomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Niraparib for glioblastomaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Niraparib for mesotheliomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Niraparib for neoplasm metastasisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1